Overview
Bexorg is a clinical-stage techbio company developing an integrated artificial intelligence and whole-human brain platform for central nervous system drug discovery and development. The company's proprietary BrainEx system restores metabolic and molecular activity in donated human brains, enabling researchers to test drug candidates in a living human neural environment before clinical trials. By combining perfusion technology with advanced machine learning models trained on comprehensive human brain datasets, Bexorg aims to reduce CNS drug development failures and accelerate the discovery of therapeutics for neurodegenerative diseases including Alzheimer's and Parkinson's disease.